The CleanPlex® Respiratory Virus Research Panel v2 combines SARS-CoV-2 whole genome amplification with 149 strategically designed primers to cover characteristic regions that span multiple gene segments for each Influenza A subtype H1N1, H1N2, H3N2, Influenza B, and RSV types A and B.

The increased target regions yield a higher coverage, resulting in higher sensitivity and making this panel more suitable for high-throughput screening strategies such as testing multi-sample pools, than qPCR methods with only 1 to 2 targets per subtype.

The respiratory virus primers were expertly designed in consideration of over 45,000 viral genome sequences to generate highly specific, but also universally conserved targets for each influenza and RSV subtype to allow confident detection throughout flu seasons, regardless of changes in strain prevalence.